IFP Advisors Inc Buys 217 Shares of Teleflex Incorporated (NYSE:TFX)

IFP Advisors Inc raised its stake in shares of Teleflex Incorporated (NYSE:TFX) by 238.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 308 shares of the medical technology company’s stock after acquiring an additional 217 shares during the quarter. IFP Advisors Inc’s holdings in Teleflex were worth $55,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in TFX. Apollon Wealth Management LLC lifted its position in Teleflex by 3.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after buying an additional 55 shares in the last quarter. SRS Capital Advisors Inc. lifted its position in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after purchasing an additional 60 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Teleflex by 0.4% during the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after purchasing an additional 65 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after purchasing an additional 66 shares in the last quarter. Finally, HighTower Advisors LLC lifted its holdings in Teleflex by 1.7% during the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after buying an additional 66 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE:TFX opened at $136.32 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.90. The firm has a 50 day simple moving average of $171.92 and a 200 day simple moving average of $202.22. The company has a market cap of $6.33 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 1.73 and a beta of 1.16.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.00%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and decreased their target price for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. Truist Financial cut their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday. Piper Sandler restated a “neutral” rating and issued a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex has an average rating of “Hold” and a consensus price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.